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Abstract The impact of polymicrobial bacterial infection
on chronic wounds has been studied extensively, but
standard bacteriological analysis is not always sensitive
enough. Molecular approaches represent a promising
alternative to the standard bacteriological analysis. This
work aimed to assess the usefulness of a panbacterial
quantitative real-time PCR reaction to quantitate the total
bacterial load in chronic wounds treated with Cutimed™
Sorbact™, a novel therapeutic approach based on hydro-
phobic binding of bacteria to a membrane. The results
obtained by panbacterial real-time PCR on conserved
sequences of the bacterial 16S gene show that the bacterial
burden significantly decreased in 10 out of 15 healing
chronic wounds, and did not change in 5 out of 5 non-
healing chronic wounds. On the contrary, classical culture
for S. aureus and P. aeruginosa, and real-time PCR for
Bacteroides and Fusobacterium did not show any correla-
tion with the clinical outcome. Our study also shows that
quantification of chronic wounds by panbacterial real-time
PCR is to be performed on biopsies and not on swabs.
These results show that panbacterial real-time PCR is a
promising and quick method of determining the total
bacterial load in chronic wounds, and suggest that it might
be an important biomarker for the prognosis of chronic
wounds under treatment.
Introduction
Chronic wounds have the important characteristic that their
healing time is not predictable and they may never heal,
causing severe physical and emotional stress to patients.
Major consequences are disability and decreased quality of
life, but also a significant financial impact on the health
care system, patients and their families.
Chronic wounds are colonized by a polymicrobial flora
[1, 2], comprising commensal bacteria, such as staphylo-
cocci, streptococci, Pseudomonas spp., and coliform bacte-
ria. Also anaerobic bacteria proliferate in the wound, owing
to the combination of necrotic tissue and low oxygen
tension [3]. The role of bacteria in wounds depends on their
concentration, species composition, and host response [4,
5]. Contamination and colonisation by low concentrations
of microbes are considered normal, and are not believed to
inhibit healing [6]. However, critical colonisation and
infection are associated with a significant delay in wound
healing [7].
Clinical microbiology has focussed on determining the
concentrations and identities of microbes associated with
wound infection. Analysis of swabs or debridement tissue
from chronic wounds, carried out by isolation on agar and
biochemical characterisation, has several shortcomings. In
fact, culture methods detect only about 1% of all bacteria
present in chronic wounds [8], and it is not possible to
isolate all bacterial species present in a specific wound.
Recently, several reports have strengthened the notion
that the polymicrobial nature of infection, and the as yet
undetermined interactions among colonizing bacteria, may
play a major role in the lack of healing of chronic wounds
[9, 10]. Therefore, determination of the bacterial burden
might be an important laboratory parameter. There is an
increasing perception that the presence of 10
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culture-based analysis) is a key determinant in delayed
wound healing. However, quantitative cultural methods
are limited in their aim to define a threshold value of
significant bacterial burden. In fact, they depend on in
vitro growth conditions and detect only viable and
cultivable bacteria. To evaluate the significance of
bacterial load in wound healing it is necessary to
quantitate the full range of germs within a wound.
Molecular methods are an attractive alternative to
determining the bacterial burden, as they can identify
even the non-cultivable micro-organisms [10, 11].
Real-time PCR, which allows precise quantification of
bacterial load, has been used to detect and quantify specific
pathogens in chronic wounds [12, 13], but it requires the
use of specific reagents for each bacterial species of
interest. An important development of real-time PCR has
been the design of “universal” primers, focussed on the 16S
rRNA gene [14, 15], a highly conserved region among all
bacteria. This approach determines the total bacterial
burden with high sensitivity, rapid results, and detection
of all bacteria, both aerobic and anaerobic.
The aim of this work was to assess the usefulness of
panbacterial real-time PCR to determine the bacterial load in
chronic wounds. The analysis was carried out in the course of
a non-comparative, pilot clinical study designed to evaluate
the efficacy of Cutimed™ Sorbact™ (BSN Medical, Ham-
burg, Germany), an innovative antimicrobial dressing for the
management of chronic wounds. Cutimed™ Sorbact™ fibres
arecoatedwithahydrophobicfattyacidthatirreversiblybinds
to the bacterial surface, and mechanically removes bacteria
from the wound at each dressing change [16–18]( www.
cutimeduk.com/cutimed-sorbact.html). This mechanism of
action can prevent or reduce treatment with antibiotics,
avoiding several drug drawbacks, such as antibiotic
resistance [19, 20].
Materials and methods
Clinical study
A non-comparative double-blind pilot study was carried out
by the Vascular Disease Center (St. Anna Hospital,
Ferrara). Ethics approval was obtained from the Ethics
Committee of the University of Ferrara.
Nineteen consecutive patients (for a total of 20
wounds) affected by chronic arterial or venous leg
ulcers were enrolled in the study and gave their written
informed consent. Exclusion criteria were: malnutrition,
systemic antibiotic treatment up to 2 weeks before the
start of the study, immunosuppression and cortisone
treatment.
Wounds were treated with a 0.9% NaCl saline solution
rinse, surgical debridement and application of Cutimed™
Sorbact™ (BSN Medical, Hamburg, Germany). Dressings
were changed twice a week and the study was performed
during a 4-week period. During dressing changes the
wounds were rinsed with saline solution, and when
necessary, PU foams, secondary covers and gold standard
elasto-compression were used. Documentation of cases was
performed using a standard wound documentation system
and special individual case report forms, including an
evaluation of wound conditions (wound size, amount of
necrosis, granulation, fibrin and epithelialisation tissue,
pain) and quality of life. Quality of life was assessed by
the SF36 questionnaire, a standardised group of questions
on general life conditions answered by the patient on a
scale from 0, being the worst condition, to 100, the best
condition.
Wound photographs were taken once a week. All
specimens were transported to the laboratory under code
to ensure the patients’ privacy.
Wound sampling
Punch biopsies were taken at the beginning and end of the
treatment with Cutimed™ Sorbact™. Swabs were taken
once a week during the dressing change. Tissue specimens,
obtained aseptically and placed in a sterile tube containing
500 μL of sterile phosphate buffered saline (PBS) were
transported to the laboratory, where they were weighed,
homogenised and lysed.
Wound swabbing was performed using the Cutimed™
Sorbact™ dressing to sample superficial wound fluid and
tissue debris. Dressings were placed into a sterile tube
containing 2 mL of sterile PBS and transported to the
laboratory. Skin swabs from six healthy donors were used
as controls.
DNA extraction
Biopsy and swab samples were incubated in 2 mL and
3 mL of lysis buffer (0.6% SDS, 10 mM Tris, 1 mM EDTA,
120 μg/mL proteinase K) at 37°C overnight.
Genomic DNA was extracted by four treatments with
phenol: chloroform: isoamyl alcohol (25:24:1). After iso-
propanol precipitation, DNA was centrifuged, washed with
75% ethanol, and re-suspended in 100 μL of sterile water.
DNA concentration was assessed by reading optical density
at 260 nm using a spectrophotometer and by a second
reading using the Qubit fluorometer (Invitrogen), thus
avoiding incorrect reading because of the presence of
RNA or proteins.
Purified DNA was stored at –20°C until real-time PCR
analysis.
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All bacterial strains were obtained from the American Type
Culture Collection (ATCC, USA), including E. coli (ATCC
10536), S. aureus (ATCC 25923), P. aeruginosa (ATCC
15442), E. hirae (ATCC 541), S. agalactiae (ATCC 12344),
B. subtilis (ATCC 6633), Bacteroides fragilis (ATCC
25285) and Fusobacterium necrophorum (ATCC 25286).
Anaerobic bacteria were grown on CDC Anaerobe Agar
with 5% Sheep Blood plates and in BBL Cooked Meat
Medium (Becton–Dickinson). Anaerobic conditions were
created using the AnaeroGen sachet in the Anaerobic Jar
(Oxoid), and assessed by the Anaerobic Indicator.
Real-time PCR
Quantitative real-time PCR was used to determine either the
amount of total bacterial genomes with a panbacterial
consensus set of primers and probe, as well as the amount
of Bacteroides and Fusobacterium genomes with specific
reactions.
The reactions were performed using the 7300 Applied
Biosystems PCR equipment. Primers, probes and reaction
conditions for panbacterial qPCR were as previously de-
scribed by Yang et al. [21], except for modification of the
reporter dye. Primer and probe sets for Bacteroides and
Fusobacterium real-time PCR were designed on sequences
deposited in GenBank (accession numbers CR626927 and
FJ410389 respectively). Primers for Fusobacterium were:
(forward) 5′-CCGCGCATTCCGTATGG -3′,( r e v e r s e )5 ′-
CGGGTAGGATCAGCCTGTTATC-3′ and the probe was
5′-(6Fam) TCGTCGCTCAACGGATAAAAGCTACCCT
(Tamra)-3′.
Primers for Bacteroides were: (forward) 5′-TTCAGGC
TAGCGCCCATT-3′,( r e v e r s e )5 ′-GGAACTGAGA
CACGGTCCAAAC-3′, and the probe was 5′-(6Fam)-
CCAATATTCCTCACTGCTGCCTCCCGTA (Tamra)-3′.
The RNaseP eukaryotic gene was amplified using a 5′-
VIC-labelled and 3′-non-fluorescent (MGB, Applied Bio-
systems) probe. RNaseP gene was simultaneously quanti-
fied to calculate the number of eukaryotic cells present in
the biopsy samples, as an internal positive control to ensure
that all samples were suitable for amplification.
Amplifications were carried out in a 50-μL total volume
containing 25 μL 2X TaqMan Universal Master Mix
(Applied Biosystems), 2.5 μL of primers and probes mix,
2.5 μL of 20X RNaseP mix and 20-μL template
corresponding to 100 ng of total DNA.
Concentrations of each primer and probe were, respec-
tively, 900 nM and 100 nM. The reaction conditions for all
templates were: 10 min at 95°C for enzyme activation,
40 cycles with 15 s at 95°C for DNA denaturation and 60 s
at 60°C for annealing and extension.
All samples were amplified in duplicate, and the average
value was calculated.
Isolation of S. aureus and P. aeruginosa by culture methods
Briefly, 1/10 volume of biopsies and swabs were plated on
Mannitol Salt agar plates (Oxoid) for the detection of S.
aureus, and on Cetrimide agar plates (Oxoid) for the
selection of P. aeruginosa. After 24 and 48 h incubation
at 37°C respectively, the number of colony-forming units
(CFU) of each micro-organism was counted for each plate.
Statistical analysis
Statistical analysis was conducted using the Stat View
software package (SAS Institute, Cary, NC, USA). The data
were analysed using the Mann–Whitney U test. Statistical
significance was assumed at p<0.05 (two-tailed).
Results
Clinical results
Responder patients were determined on the basis of a
positive Margolis index (reduction of more than 50% of the
wound area). Clinical conditions improved significantly in
7 of the 20 cases treated with Cutimed™ Sorbact™ (35%
responder patients, 77.49% average reduction of the area),
with complete healing in 2 cases. In another 8 cases general
improvement of the wound conditions were observed, even
if the wound area decreased less than 50% (average 38.33%
reduction). In 1 case the wound area showed no variation
and in the remaining 4 cases there was an increase (34.48%
mean increase of the area). Table 1 shows the results of
wound reduction in each patient, in comparison with the
quantitation of bioburden and bacterial presence.
Bacterial load in chronic wounds
Quantification of the total bacterial load was assessed by
comparison with a standard curve obtained by 10-fold
serially diluted purified DNA of E. coli.
Reactions were performed on 100 ng of total DNA from
biopsies, amplifying simultaneously both the highly con-
served bacterial 16S rRNA gene and the eukaryotic RNaseP
gene, used as an internal control for assessment.
In the case of swabs, reactions were performed on
100 ng of extracted DNA amplifying the bacterial 16S
rRNA gene, and the results were normalised to the total
volume of extraction buffer.
The average bacterial load in normal healthy skin was
4.5×10
5 bacteria per swab, representing the normal flora.
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sample the variation in bacterial load and wound reduction,
during the 4 weeks of treatment with Cutimed™ Sorbact™.
According to the results, the samples can be divided
into three groups. The first group is formed by samples
where the positive clinical outcome is concordant with
molecular data. In particular, 10 out of 15 wounds
(66%) with a positive clinical outcome and with 58%
mean reduction of the wound’s area, showed a signif-
icant decrease in the total bacterial load. The initial
bacterial load was considerably different in the samples,
rangingfrom4.38×10
3 to 2.44×10
8 bacterial genomes/mg of
tissue. Nevertheless, the average of the total bacterial load at
the beginning of treatment was 4.41×10
7/mg of tissue, and
at the end decreased to 1.73×S10
5/mg of tissue,
corresponding to a 254-fold decrease in the total bacterial
load (Fig. 1). The decrease in bacterial load was statistically
significant (p=0.0243).
The analysis of swabs from the same wounds, collected
once a week for 4 weeks, showed less variability among
samples from different patients. The majority of specimens
yielded over 10
9 total bacteria at the initial sampling.
Analysis of subsequent time points failed to show any
significant decrease. In fact, in spite of clinical positive
outcome, the bacterial load remained constantly high,
ranging from 2.63×10
10 in the first samples to 9.37×10
9
bacterial genomes/swab in the final samples (Fig. 1).
The second group is formed by five chronic wounds
with a negative clinical course, no response to treatment,
and averaged a 27% increase in the wound area. The total
bacterial load of biopsies showed a non-significant 5.2-fold
decrease at the end of the treatment (2.73×10
6 to 5.22×10
5
bacterial genomes/mg of tissue; p=0.6; Fig. 1). Also, the
swabs from these five cases did not show any significant
change in bacterial load throughout the 4-week period of
the study (Fig. 1).
Table 1 Summary of results obtained for each patient
Patients Δ Area
(%)
a
Δ Total bacterial load
(biopsies) (%)
b
Δ Total bacterial
load (swabs) (%)
b
Δ Bacteroides load
(biopsies) (%)
c
Δ Fusobacterium load
(biopsies) (%)
c
Staphylococcus
(biopsies)
d
Pseudomonas
(biopsies)
d
First Last First Last
1 −100 −100 −99.96 −100 – −−− −
2 −50 −99.98 +73.33 −99.99 – +++ +
3 −100 −100 −99.08 –– −−− −
4 −90 −99.68 +70.93 –– −−− −
5 −71.4 −99.17 −84.45 −99.998 – + −− −
6 −40 −98.28 −73.35 −100 – + −− −
7 −42.6 −91.45 −91.69 –– + −− −
8 −34.6 −92.09 +36.51 –– −−− −
9 −21.3 −87.85 +99.82 +57.33 – −−− +
10 −46.3 −85.53 −50.6 −85.32 −100 + + −−
11 +5.8 +98.22 −99.98 +36.09 – ++−−
12 +72.7 +19.13 −99.74 –– −−− −
13 +58.3 +41.06 +62.84 –– ++−−
14 −0.5 −97.66 +92.93 −99.83 – −−+ −
15 +1.1 −27.29 +43.08 +94.43 – −−− −
16 −44.7 +95.53 −77.97 +83.33 – +++ +
17 −64.3 −43.81 +99.98 –– + −− −
18 −33.3 +11.48 +99.82 –– + −− −
19 −43.8 +24.49 +99.63 – −70 + + −−
20 −66.7 +80.4 −99.72 –– − + −−
aΔ Area shows the decrease (negative value) or the increase (positive value) in wound area at the end of the study, compared with the beginning,
expressed as a percentage
bΔ Total bacterial load shows the decrease (negative value) or the increase (positive value) in total bacterial load at the end of the study, compared
with the beginning, as determined by panbacterial real-time PCR. Values are expressed as percentages, in biopsies and swabs respectively
cΔ Bacteroides and Fusobacterium load show the percentage decrease (negative value) or the increase (positive value) in bacterial load at the end
of the study compared to the beginning, as determined by specific real-time PCR
dColumns labelled Staphylococcus and Pseudomonas show the presence of these germs in first and last biopsies as determined by conventional
culture methods
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wounds with a positive clinical outcome (average 50%
decrease in the affected area), but no reduction in the total
bacterial load in biopsies. In fact, a slight, non-significant
5.3-fold reduction was recorded (p=0.75; Fig. 1). Similarly,
the total bacterial load in swabs did not change during
treatment (Fig. 1).
Search for specific bacterial species in chronic wounds
Biopsies from chronic wounds were analysed using
classical culture methods by plating on selective agar for
the detection of S. aureus and P. aeruginosa. The colony
count in the normal healthy skin was under 100 CFU. The
results are summarised in Table 1. S. aureus was detected in
10 out of 20 biopsies at the beginning of the study, and
persisted in 7 cases. P. aeruginosa was detected in 3
samples both in the initial and the final biopsies. As shown
in Table 1, there was no correlation with the clinical
outcome, nor with the results of panbacterial real-time PCR.
For example, patient 1 had a complete clinical recovery,
with a marked decrease in bacterial load by qPCR, in the
complete absence of S. aureus and P. aeruginosa in both
biopsies. By contrast, patient 2 had a significant clinical
outcome and a corresponding decrease in bacterial load,
with the presence of higher than normal loads of S. aureus
and P. aeruginosa, both in the first and in the last biopsy.
We also searched using real-time PCR for the specific
presence of Fusobacterium and Bacteroides species, two
anaerobe bacteria frequently detected in chronic wounds.
Sensitivity of reaction, and standard curve were determined
in serial dilutions of genomic DNA and plasmids contain-
ing the amplified region of Fusobacterium and Bacteroides.
Both reactions were sensitive enough to detect as few as
100 total genomes. No cross-reaction between primer and
probe sets was observed, and no amplification of eukaryotic
cell DNA and other bacterial DNA was present using these
sets of primers. The linear range of amplification was
achieved from 10
3 to 10
7 total molecules (data not shown).
Bacteroides was found in 10 out of 20 wounds (50%).
Bacteroides load averaged 8×10
7 genomes/mg of tissue in
the first biopsy, and 4×10
5 in the final biopsy, showing a
197-fold decrease after treatment with Cutimed™ Sorbact™
with no statistical difference between the first and last biopsy
(p=0.1). In particular, with the exception of two samples
where Bacteroides disappeared after Cutimed™ Sorbact™
treatment, all cases positive in the first biopsy were also
positive in the final biopsy.
More specifically, the presence of Bacteroides DNA was
irrespective of the clinical outcome, being present in 6
Fig. 1 Total bacterial load
determined by panbacterial real-
time PCR in biopsies and in
swabs. Samples from patients
have been grouped according to
the clinical outcome. a Average
bacterial load in biopsies with
concordant clinical and molecu-
lar results. b Average bacterial
load in corresponding swabs. c
Average bacterial load in
biopsies with a positive clinical
result, but no significant
decrease in average bacterial
load. d Average bacterial load in
corresponding swabs. e Average
bacterial load in biopsies that
did not have a positive clinical
result. f Average bacterial load
in corresponding swabs
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correlation between total bacterial load and clinical out-
come), in 3 wounds of the second group (absence of
positive clinical result) and in 1 wound of the third group of
samples (positive clinical result with no decrease in total
bacterial load).
Fusobacterium DNA was found in 2 out of 20 wounds
(10%). The initial load was 1.7×10
4 genomes/mg of tissue,
and the load showed a non-significant 3.5-fold decrease
(4.9×10
3 genomes/mg) after treatment with Cutimed™
Sorbact™.
Discussion
This work aimed for the first time to verify the suitability of
real-time PCR quantification of total bacterial load as a
quick and sensitive laboratory parameter. To achieve the
goal, a panbacterial real-time PCR based on amplification
of a conserved region of the 16S gene was set up, and
verified on the genome of six different bacteria. The results
show that this approach is sensitive and allows precise
quantification over a broad range of concentrations (from
100 to 10
7 target molecules). Subsequently, this method of
analysis was applied in the course of a pilot study on the
use of Cutimed™ Sorbact™, a membrane with hydropho-
bic properties that binds and retains bacteria, for treatment
of chronic wounds.
The clinical results show that Cutimed™ Sorbact™
treatment resulted in complete success of the therapy in 7
out of 20 patients, and a general improvement in another 9
patients, even if the reduction of wound area was less than
50%. This positive outcome has to be evaluated considering
that the wounds selected were persistent and resistant to
other therapeutic options.
The laboratory results on panbacterial real-time PCR
show that the total bacterial load significantly decreased in
10 out of 15 healing chronic wounds and did not change in
5 out of 5 non-healing chronic wounds. Furthermore,
bacterial load decreased in biopsies, but not in swabs.
Classical microbiology for two aerobes widely predominant
in chronic wounds (S. aureus, P. aeruginosa) did not show
any correlation with the clinical outcome of the therapy.
Also, molecular quantification for two anaerobes often
implicated in chronic wounds (Bacteroides spp., Fusobac-
terium spp.) did not show any correlation with the clinical
outcome.
Several observations arise from this study. The first
shows that panbacterial real-time PCR is a reliable method
of assessing the therapeutic success of chronic wound
treatment. In fact, 10 out of 15 chronic wounds with
complete or partial therapeutic success showed a significant
decrease in total bacterial load, and no decrease was
observed in 5 out of 5 wounds with no clinical improve-
ment. In total, the results of real-time PCR were concordant
with clinical results in 15 out of 20 chronic wounds,
indicating that total bacterial load might be considered as a
useful biomarker for treatment prognosis. The scientific
literature highlights the need for prognostic indicators of
chronic ulcers. A recent review enumerates several poten-
tial biomarkers (cytokines, proteases and their inhibitors,
senescence markers, oxidative stress, microbiological sta-
tus, etc.), but concludes that no available data reflect wound
progression or regression [22]. Our study indicates that
panbacterial real-time PCR might fill this need.
Another observation is that quantitation studies of
chronic wounds by panbacterial real-time PCR requires
analysis of biopsies. In fact, no significant result was
obtained by analysis of swabs. Even if this result cannot be
explained at this time, there are several reports indicating
that swab analysis gives inconsistent results [23]. The
Centers for Disease Control recommend either tissue biopsy
or fluid aspiration methods to determine the bacterial
content of wounds [24, 25]. It is possible that chronic
wounds, even at an advanced stage of healing, are still
colonised by a high number of bacteria at the surface, while
infection of deep tissues has been eliminated. According to
this hypothesis, positive bacterial swabs would indicate just
the presence of colonising bacteria, while infectious
processes are being eliminated.
Our results show that the analysis of specific pathogens,
even using molecular techniques, is much less effective
than panbacterial real-time PCR, and could even be
misleading. In fact, by conventional culture S. aureus and
P. aeruginosa were not detected in sample number 12
(Table 1), and yet this lesion was refractory to treatment
and showed a substantial increase in the wound area.
Furthermore, both bacteria continued to be present in
sample number 2, even if this lesion responded well to
the therapy with a significant decrease in the affected area,
and a consistent decrease in the bacterial load. A similar
situation was detected by analysis of anaerobes by real-time
PCR. No significant decrease in Bacteroides spp. was
recorded in healing wounds, and this anaerobic bacteria had
similar loads in healing and non-healing lesions (Table 1).
At the moment it is not possible to explain with
convincing arguments the fact that five chronic wounds
showed a positive clinical outcome with no decrease in total
bacterial burden. Plausible explanations are that the
bacterial population in these wounds was only a minor
pathogenic component, or that the presence of bacteria
reflected colonising, but not infecting micro-organisms.
Alternatively, it is possible that these five lesions showed a
fungal or yeast component [26] that was removed by the
dressing. Another possible explanation is that there was a
switch in the composition of the bacterial population, and
1528 Eur J Clin Microbiol Infect Dis (2012) 31:1523–1529that more aggressive bacteria present in the first biopsy had
been replaced in the last biopsy by commensal micro-
organisms. However, it should be noted that S. aureus, P.
aeruginosa and Bacteroides spp. were not involved in this
hypothetical process.
In conclusion, despite the small number of samples
analysed, these results show that panbacterial qPCR is a
promising, quick method of determining the total bacterial
load in chronic wounds, and suggest that it might be an
important biomarker for the prognosis of chronic wounds
under treatment.
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